Pharmafile Logo

Lifting the fog to help Clinical Labs navigate IVDR 2022

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers and prospects know that they were by their side to help them navigate these changes – plus showcase their devices planned for IVDR-compliance.

The brief

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.

BD wanted to let their customers and prospects know that they were by their side to help them navigate these changes – plus showcase their devices planned for IVDR-compliance.

The insight

IVDR couldn’t be ignored or poorly understood by labs – it’s happening on 26 May 2022. For those unprepared, it could mean huge disruption, confusion and a loss of revenue.

Our solution

We didn’t want to simply tell customers why they should prepare for IVDR, we wanted to show them, by creating something engaging, emotive and unique.

Lift The Fog was just that – a mini-series that told the story of the Atlantis and her crew, lost at sea, to get labs’ attention and warn them of the dangers of ignoring IVDR. The stories were carefully crafted to mirror the trials unprepared laboratories could face and create a sense of urgency for lab managers. BD was then positioned as the trusted partner to help them navigate the changes.

The results

  • 68% average click-through rate
  • 78 qualified leads generated
  • Multiple awards won (including Gold Cannes Corporate Dolphin – Branded Content)
  • Season 2 – coming soon

See the full case study here.

This content was provided by Create Health

Company Details

 Latest Content from  Create Health 

Healthcare marketing agency Create Health continues to grow

Eight new recruits, including Business Development Director, Marketing Manager and Medical Writer join Create Health.

Lifting the fog to help Clinical Labs navigate IVDR 2022

In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests.  BD wanted to let their customers...

Empowering adolescents to manage emotional and mental health issues

1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...

Reframing rare to increase earlier diagnosis of Gaucher Disease

Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...

Proving the power of a positive mindset to help fix all ills

There’s a huge amount of fear around health conditions and disease – in fact according to Harvard Medical School, health anxiety affects 12% of adults. We wanted to put a...

Creating a monster to distrupt the market and solve a chronic problem

ConvaTec launched AQUACEL Ag+ in 2014, a new class of dressing proven to disrupt and destroy biofilm. They came to us to help them position AQUACEL Ag+ as the solution...

Inspiring researchers to find the impossible with a next generation solution

Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to...

Keeping the food industry safe with next level protection solutions

Thermo Fisher Scientific came to us when they needed to communicate their New Generation food production technologies.

Empowering the GP to help women feel the vagisil prohydrate difference

Vagisil were launching their first product available on prescription. It was a tough task to put Vagisil ProHydrate front of mind and turn GPs into advocates. That’s why they came...